EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Clinical trial NCT06375954 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06375954
Sponsor: Hospital Universitari de Bellvitge
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Malignant Biliary Obstruction Pancreatic Cancer Biliary Tract Neoplasms

Start date: 2024-05-01
Primary completion: 2026-06-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.